ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
Karineh Petrossian(Beckman Research Institute), Shiuan Chen(City Of Hope National Medical Center)
Cited by 18
Related Papers
Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway
|Cancer Research|2010|217
Heat Shock Protein 90 Inhibitors: New Mode of Therapy to Overcome Endocrine Resistance
|Cancer Research|2009|34
Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment
|Clinical and Translational Medicine|2024|12